Denali Therapeutics Inc (DNLI)
Operating Expenses
$134.05M
Quarterly · Period ending: · USD
DNLI Operating Expenses
Latest reported$134.05Mperiod ending
Latest reported$134.05Mperiod ending
DNLI Quarterly Operating Expenses ($18.36M → $134.05M)
Quarterly operating expenses
High-resolution chart · PNG
DNLI operating expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 134,052,000 | |
| 134,512,000 | |
| 134,499,000 | |
| 137,434,000 | |
| 134,963,000 | |
| 145,580,000 | |
| 129,846,000 | |
| 123,187,000 | |
| 116,593,000 | |
| 117,715,000 | |
| 132,572,000 | |
| 115,062,000 | |
| 123,640,000 | |
| 155,956,000 | |
| 115,627,000 | |
| 111,045,000 | |
| 113,896,000 | |
| 108,639,000 | |
| 89,635,000 | |
| 90,878,000 | |
| 84,756,000 | |
| 79,143,000 | |
| 72,737,000 | |
| 69,509,000 | |
| 67,124,000 | |
| 63,571,000 | |
| 62,430,000 | |
| 63,759,000 | |
| 66,960,000 | |
| 46,713,000 | |
| 50,954,000 | |
| 39,159,000 | |
| 59,030,000 | |
| 26,389,000 | |
| 23,540,000 | |
| 22,288,000 | |
| 22,568,000 | |
| 21,744,000 | |
| 19,866,000 | |
| 30,932,000 | |
| 18,362,499 | |
| 18,362,499 |